Grant Awardees March-April 2015

Thursday, May 07, 2015

 

Congratulations to Carver College of Medicine Grant Awardees from March-April 2015!

Name Department Sponsor Proposal Title
Abel, E. Dale Internal Medicine US Department of Health & Human Services, National Institutes of Health Insulin Inhibition of betaAR signaling in the myocardium
Ahrens, Richard Pediatrics N30 Pharmaceuticals, Inc. A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients with Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Ahrens, Richard Pediatrics Seattle Children's Research Institute Early Intervention in Cystic Fibrosis Exacerbation (eICE)
Anderson, Michael Molecular Physiology & Biophysics US Department of Veterans Affairs Therapy of Nocturnal Intraocular Pressure Elevation Causing Glaucoma Progression
Bender, David Obstetrics & Gynecology Society of Gynecologic Oncology SGO Cervical Outcomes Registry
Berg, Daniel Internal Medicine Millennium Pharmaceuticals, Inc. A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Boyden, Alexander Pathology National Multiple Sclerosis Society The role of CD8+ regulatory T cells in modulating B cell function during EAE
Brennan, Timothy Anesthesia Concentric Analgesics, Inc. Effect of CA-008 infiltration on Acute Pain from Incision
Brophy, Patrick Pediatrics Amgen, Inc. Amgen Study 20130356
Brophy, Patrick Pediatrics Seattle Children's Research Institute Recombinant Erythropoientin Protects Against Chronic Kidney Disease
Comellas, Alejandro Internal Medicine AstraZeneca Pharmaceuticals LP A 12-week Phase IIa, Double-blind, Placebo-controlled, Randomized Study
Cullen, Joseph Surgery US Department of Health & Human Services, National Institutes of Health Pharmacological Ascorbate as a Radiosensitizer in Pancreatic Cancer
Ellermeier, Craig Microbiology Entera Health, Inc. Entera Health
Engelhardt, John Anatomy & Cell Biology US Department of Health & Human Services, National Institutes of Health Center for Gene Therapy of Cystic Fibrosis
Ford, Bradley Pathology Accelerate Diagnostics, Inc. Accelerate Clinical Trial Clinical Lab Model
Ford, Bradley Pathology Cepheid Cepheid Clinical Study
Giudici, Michael Internal Medicine Cardionomic, Inc. Cardiac Autonomic Nerve Activation to Increase Contractility
Giudici, Michael Internal Medicine Medtronic, Inc. VICTORY AF trial
Grobe, Justin Pharmacology American Diabetes Association Required Interaction of Leptin with Angiotensin in Metabolic Control
Hansen, Marlan Otolaryngology - Head & Neck Surgery Auris Medical Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 2 (TACTT2)
Hodgson-Zingman, Denice Internal Medicine St. Jude Medical, Inc. EP Fellowship Grant 2015-16 academic year
Hoffman, Eric Radiology US Department of Health & Human Services, National Institutes of Health Defining the role of early pulmonary vascular disease in COPD
Hoffman, Eric Radiology US Department of Health & Human Services, National Institutes of Health SPIROMICS-Radiology Center
Horwitz, Phillip Internal Medicine Edwards Lifesciences LLC PARTNER 2 Sapien 3i Continued Access Protocol (CAP)
Horwitz, Phillip Internal Medicine St. Jude Medical, Inc. Interventional Cardiology Fellowship Grant 2015-16 academic year
Ince, Dilek Internal Medicine Chimerix, Inc. A Phase 3, Open-label, Multicenter Study of the Safety/Tolerability and Efficacy of Brincidofovir (CMX001) for the Prevention of Adenovirus (AdV) Disease in Subjects with Asymptomatic AdV Infection at Risk of Progression and for the Treatment of Subjects
Joshi, Charuta Pediatrics GW Pharmaceuticals JOSHI- GW Pharmaceuticals - GWEP1423
Joshi, Charuta Pediatrics GW Pharmaceuticals JOSHI - GW Pharmaceuticals - An open label extension study to investigate the safety of cannabidiol (GWP42003-P; CBD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes
Kline, Joel Internal Medicine Amgen, Inc. A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and
Light-McGroary, KellyAnn Internal Medicine RiboCor, Inc. A Randomized, Double-Blind, Placebo-controlled Study To Evaluate D-Ribose For The Treatment Of Congestive Heart Failure
Lim, Tiffany Yue-Fai Microbiology US Department of Health & Human Services, National Institutes of Health The Role of Inflammasomes in Bacterial Co-Infection during Cutaneous Leishmaniasis
Lindgren, Scott Pediatrics US Department of Health & Human Services, National Institutes of Health Comparing Behavioral Asssessments Using Telehealth for Children with Autism
Link, Brian Internal Medicine Kite Pharma, Inc. Outcomes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma: Analysis of the University of Iowa/Mayo Clinic Molecular Epidemiology Resource
Mahajan, Vinit Ophthalmology & Visual Sciences US Department of Health & Human Services, National Institutes of Health Mechanism-based Therapies for Photoreceptor Degeneration
Mahajan, Vinit Ophthalmology & Visual Sciences US Department of Health & Human Services, National Institutes of Health Evaluating GWAS AMD Candidate Loci by Gene Editing in Human iPS Cells
Mangalam, Ashutosh Pathology National Multiple Sclerosis Society Therapeutic potential of combination therapy using Human Gut-derived commensal bacteria and conventional MS drugs
Mathews, Katherine Pediatrics Sarepta Therapeutics Sarepta 203
Mathews, Katherine Pediatrics Sarepta Therapeutics Sarepta 204
Mathews, Katherine Pediatrics Pfizer, Inc. Pfizer 210966/B5161002 Study
Milhem, Mohammed Internal Medicine Mayo Clinic A Randomized Phase II Study of Sequential Biotherapy with Aflibercept and High Dose IL-2 versus High Dose IL-2 alone in Patients with Inoperable Stage III or Stage IV Melanoma: Efficacy and Biomarker Study.
Milhem, Mohammed Internal Medicine NewLink Genetics Corporation A Phase IIB Study of Ipilimumab with or without HyperAcute-Melanoma Immunotherapy for Stage IV Melanoma Patients
Milhem, Mohammed Internal Medicine Janssen Research & Development, Inc. A randomized controlled study of YONDELIS (Trabectedin) or Dacarbazine for the treatment of advanced liposarcoma or Leiomyosarcoma previously treated with Anthracycline and Ifosfamide
Milhem, Mohammed Internal Medicine Northwestern University NU 13S02 Multicenter, Open-Label Phase II Study of Daily Oral Regorafenib for
Miller, Delwyn Psychiatry Otsuka Pharmaceutical Company, Ltd. PRELAPSE - A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment with Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Nugent, Andrew Program in Emergency Medicine EPIC Research and Diagnostics, Inc. EPIC Traumatic Brain Injury Feasibility Study
Paulsen, Jane Psychiatry University of California, Irvine CSF-Enhanced-Aggregation Biomarker to Monitor Huntington's Disease Progression
Paulsen, Jane Psychiatry University of Michigan Validation of the HD-HRQoL (Huntington Disease Quality of Life Measure)
Paulsen, Jane Psychiatry Auspex Pharmaceuticals, Inc. An Open-Label, Long Term Safety Study of SD-809 ER in Patients with Chorea Associated with Huntington Disease (ARC-HD)
Philibert, Robert Psychiatry University of Georgia Vulnerability to Drug Use and HIV: Advancing Prevention for Rural African Americans
Pieper, Andrew Psychiatry Calico Calico / Pieper Laboratory
Polyak, Steven Internal Medicine AbbVie Inc. A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis
Polyak, Steven Internal Medicine University of Michigan A Randomized Controlled Trial of High Dose Vitamin D Therapy in Crohn's Disease
Price, Nathan Pediatrics Duke University A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents and Children with Suspected or Confirmed Bacterial Infection
Randak, Christoph Pediatrics Cystic Fibrosis Foundation Potentiating F508 CRTR Channel Function with an Adenylate Kinase Inhhibitor
Rosenthal, Gary Internal Medicine University of Kansas Medical Center Research Institute, Inc. Greater Plains Collaborative Clinical Data Research Network
Roy, Rupali Internal Medicine Pharmacyclics, Inc. A Multicenter Open-Label Phase 2a Study of Ibrutinib With or
Sabharwal, Rasnapreet Internal Medicine Tarix Pharmaceuticals Limited Neurohumoral Actions of Angiotensin-(1-7) Analogs in Limb Girdle MD and ALS
Samuel, Isaac Surgery Foundation for Surgical Fellowships Fellowship in Bariatric Surgery
Schartz, Kevin Radiology US Department of Health & Human Services, National Institutes of Health Modern ROC Software for Multi- and Single-Reader Diagnostic Imaging Studies
Schartz, Kevin Radiology University of California, Santa Barbara Utility-Based Assessment of Diagnostic Imaging Performance
Schultz, Michael Radiology University of Texas Health Science Center at Houston Development of Hybrid Somatostatin Analogs for Surgical Guidance
Schultz, Susan Psychiatry University of California, San Diego Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease - Tau (A4-Tau) Addendum
Segar, Jeffrey Pediatrics InfaCare Pharmaceutical Corporation A 48-52 Month Blinded-Outcomes Follow Up Study of Patients Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-205
Serrano Russi, Alvaro Pediatrics Arkansas Children's Hospital Research Institute IBEM-IS Data Entry Project
Sigmund, Curt Pharmacology American Heart Association University of Iowa Strategically Focused Hypertension Research Center
Stapleton, Jack Internal Medicine Bavarian Nordic BN-POX-MVA-037
Stapleton, Jack Internal Medicine US Department of Veterans Affairs The effects of Hepatitis C Virus (HCV) E2 protein on host immunomodulation
Stevens, Hanna Psychiatry Robert Leet & Clara Guthrie Patterson Trust Developmental Psychopathology and Prenatal Stress Mechanisms and Prevention of Risk
Stevens, Hanna Psychiatry Yale University Behavioral Epidemiology of Intensive In-Home Child and Adolescent Psychiatric Services
Stone, Edwin Ophthalmology & Visual Sciences Foundation Fighting Blindness FFB-MAK-Associated RP Research Fund
Taylor, Eric Biochemistry US Department of Health & Human Services, National Institutes of Health Regulation of Hepatic Gluconeogenesis by the Mitochondrial Pyruvate Carrier
Tricot, Guido Internal Medicine Novartis Pharmaceuticals Corporation Exploit whether LBH589 can deplete the myeloma drug-resistant fraction
Turvey, Carolyn Psychiatry Baylor College of Medicine One-Day Intervention for Depression and Impairment in Migraine Patients
Vaena, Daniel Internal Medicine Bristol-Myers Squibb Company A Phase II Single Arm Clinical Trial of Nivolumab (BMS-936558) in Subjects with Metastatic or Unresectable Urothelial Cancer who have Progressed or Recurred Following Treatment with a Platinum Agent
Vaena, Daniel Internal Medicine TRACON Pharmaceuticals, Inc. A Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone (Including a Lead-In Phase 1B Dose-Escalation Portion) in Patients with Advanced or Metastatic Renal Cell Carcinoma
Vaena, Daniel Internal Medicine AstraZeneca Pharmaceuticals LP A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients with Papillary Renal Cell Carcinoma (PRCC)
Weigel, Ronald Surgery US Department of Health & Human Services, National Institutes of Health RET as a Novel Therapeutic Target for Breast Cancer
Weiner, George Cancer Center US Department of Health & Human Services, National Institutes of Health Cancer Center Support Grant - (CCSG)
Weiss, David Microbiology US National Science Foundation REU Site: Microbiology at The University of Iowa
Wibbenmeyer, Lucy Surgery Queen's University, Kingston General Hospital, Ontario, Canada A Randomized Trials of the Enteral Glutamine to Minimize Thermal Injury
Xue, Hai-Hui Microbiology US Department of Health & Human Services, National Institutes of Health Tcf/Lef-b-catenin in T cell identity and cancer
Zavazava, Nicholas Internal Medicine ReproCELL Inc. 3D Differentiation of human-induced pluripotent stem cells into insuling-producing cells using a bioactive ECM scaffold
Date: 
Thursday, May 7, 2015